Jounce Therapeutics, Inc.
Jounce Therapeutics, Inc. (JNCE) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · JNCE · as of Jun 9, 2026
Activity summary
Buy transactions
2
P-Purchase only
Sell transactions
9
12 Months
Buy/Sell ratio
0.22
Buy/Sell (by trades)
Overall sentiment
Jounce Therapeutics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
JNCE insider buying and selling by quarter
JNCE insider selling · JNCE insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Recent insider transactions
JNCE executive sell shares · JNCE board member insider trading · JNCE insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 3, 2023 | Concentra Biosciences, LLC 10 percent owner | Other | 10,000 | $97.38M⚡ | Form 4 |
| May 3, 2023 | TANG KEVIN C Director | Other | 10,000 | $97.38M⚡ | Form 4 |
| May 3, 2023 | TANG KEVIN C Director | Other | 5,300,087 | $9.81M⚡ | Form 4 |
| May 3, 2023 | MURRAY RICHARD /CA/ Director | Other | 188,778 | $349K | Form 4 |
| May 3, 2023 | KARSEN PERRY A Director | Other | 5,000 | $9K | Form 4 |
| May 3, 2023 | Kamen Robert Director | Other | 33,875 | $63K | Form 4 |
| May 3, 2023 | Drapkin Kimberlee C President, CFO and Treasurer | Other | 25,751 | $48K | Form 4 |
| May 3, 2023 | Drapkin Kimberlee C President, CFO and Treasurer | Other | 40,267 | $74K | Form 4 |
| Apr 4, 2023 | MURRAY RICHARD /CA/ Director | Sale | 39,228 | $73K | Form 4 |
| Mar 14, 2023 | TANG KEVIN C 10 percent owner | Purchase | 20,286 | $21K | Form 4 |
| Mar 13, 2023 | TANG KEVIN C 10 percent owner | Purchase | 65,701 | $65K | Form 4 |
| Jan 9, 2023 | Trehu Elizabeth Chief Medical Officer | Sale | 4,159 | $5K | Form 4 |
| Jan 10, 2023 | Trehu Elizabeth Chief Medical Officer | Sale | 5,126 | $6K | Form 4 |
| Jan 9, 2023 | MURRAY RICHARD /CA/ CEO and President | Sale | 20,191 | $22K | Form 4 |
| Jan 10, 2023 | MURRAY RICHARD /CA/ CEO and President | Sale | 24,879 | $28K | Form 4 |
| Jan 9, 2023 | Drapkin Kimberlee C CFO and Treasurer | Sale | 6,315 | $7K | Form 4 |
| Jan 10, 2023 | Drapkin Kimberlee C CFO and Treasurer | Sale | 7,781 | $9K | Form 4 |
| Jan 9, 2023 | Cole Hugh M COO | Sale | 7,452 | $8K | Form 4 |
| Jan 10, 2023 | Cole Hugh M COO | Sale | 9,182 | $10K | Form 4 |
| Feb 1, 2022 | Cole Hugh M Chief Business Officer | Award | 42,500 | — | Form 4 |
| Feb 1, 2022 | Drapkin Kimberlee C CFO and Treasurer | Award | 27,500 | — | Form 4 |
| Feb 1, 2022 | MURRAY RICHARD /CA/ CEO and President · Director | Award | 87,500 | — | Form 4 |
| Feb 1, 2022 | Trehu Elizabeth Chief Medical Officer | Award | 27,500 | — | Form 4 |
| Jan 7, 2022 | Trehu Elizabeth Chief Medical Officer | Sale | 3,005 | $22K | Form 4 |
| Jan 10, 2022 | Trehu Elizabeth Chief Medical Officer | Sale | 5,378 | $36K | Form 4 |
Concentra Biosciences, LLC
10 percent owner
Date
May 3
Shares
10,000
Price
$9737.70
Value
$97.38M ⚡
Drapkin Kimberlee C
President, CFO and Treasurer
Date
May 3
Shares
25,751
Price
$1.85
Value
$48K
Drapkin Kimberlee C
President, CFO and Treasurer
Date
May 3
Shares
40,267
Price
$1.85
Value
$74K
Trehu Elizabeth
Chief Medical Officer
Date
Jan 9
Shares
4,159
Price
$1.10
Value
$5K
Trehu Elizabeth
Chief Medical Officer
Date
Jan 10
Shares
5,126
Price
$1.12
Value
$6K
MURRAY RICHARD /CA/
CEO and President
Date
Jan 9
Shares
20,191
Price
$1.10
Value
$22K
MURRAY RICHARD /CA/
CEO and President
Date
Jan 10
Shares
24,879
Price
$1.12
Value
$28K
Drapkin Kimberlee C
CFO and Treasurer
Date
Jan 9
Shares
6,315
Price
$1.10
Value
$7K
Drapkin Kimberlee C
CFO and Treasurer
Date
Jan 10
Shares
7,781
Price
$1.12
Value
$9K
MURRAY RICHARD /CA/
CEO and President · Director
Date
Feb 1
Shares
87,500
Price
—
Value
—
Trehu Elizabeth
Chief Medical Officer
Date
Jan 7
Shares
3,005
Price
$7.30
Value
$22K
Trehu Elizabeth
Chief Medical Officer
Date
Jan 10
Shares
5,378
Price
$6.65
Value
$36K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About JNCE insider trading
JNCE insider trades
Jounce Therapeutics, Inc. (JNCE) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including JNCE. Over the past 12 months, 0 insiders have filed transactions with the SEC. JNCE insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Jounce Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
JNCE insider trading · 5 questionsThe insiders of Jounce Therapeutics, Inc. (JNCE) include executives and directors such as JNCE, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026